vs
Side-by-side financial comparison of Latham Group, Inc. (SWIM) and Travere Therapeutics, Inc. (TVTX). Click either name above to swap in a different company.
Travere Therapeutics, Inc. is the larger business by last-quarter revenue ($129.7M vs $100.0M, roughly 1.3× Latham Group, Inc.). On growth, Travere Therapeutics, Inc. posted the faster year-over-year revenue change (73.4% vs 14.5%). Over the past eight quarters, Travere Therapeutics, Inc.'s revenue compounded faster (77.0% CAGR vs -4.9%).
Latham & Watkins LLP is an American multinational law firm. Founded in 1934 in Los Angeles, California, it is known for its litigation, corporate, and regulatory law practices.
Travere Therapeutics, Inc. is a global biopharmaceutical firm developing and commercializing innovative therapies for patients with rare, serious, life-threatening diseases. Its key segments cover rare nephrology, hepatology and metabolic disorders, serving markets across North America, Europe and other global regions.
SWIM vs TVTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $100.0M | $129.7M |
| Net Profit | $-7.0M | — |
| Gross Margin | 28.0% | 98.0% |
| Operating Margin | -10.7% | -25.0% |
| Net Margin | -7.0% | — |
| Revenue YoY | 14.5% | 73.4% |
| Net Profit YoY | 76.0% | — |
| EPS (diluted) | $-0.06 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $100.0M | $129.7M | ||
| Q3 25 | $161.9M | $164.9M | ||
| Q2 25 | $172.6M | $114.4M | ||
| Q1 25 | $111.4M | $81.7M | ||
| Q4 24 | $87.3M | $74.8M | ||
| Q3 24 | $150.5M | $62.9M | ||
| Q2 24 | $160.1M | $54.1M | ||
| Q1 24 | $110.6M | $41.4M |
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $8.1M | $25.7M | ||
| Q2 25 | $16.0M | $-12.8M | ||
| Q1 25 | $-6.0M | $-41.2M | ||
| Q4 24 | $-29.2M | — | ||
| Q3 24 | $5.9M | $-54.8M | ||
| Q2 24 | $13.3M | $-70.4M | ||
| Q1 24 | $-7.9M | $-136.1M |
| Q4 25 | 28.0% | 98.0% | ||
| Q3 25 | 35.4% | 99.0% | ||
| Q2 25 | 37.1% | 98.7% | ||
| Q1 25 | 29.5% | 94.3% | ||
| Q4 24 | 24.6% | 96.6% | ||
| Q3 24 | 32.4% | 97.4% | ||
| Q2 24 | 33.1% | 96.2% | ||
| Q1 24 | 27.7% | 96.4% |
| Q4 25 | -10.7% | -25.0% | ||
| Q3 25 | 13.3% | 15.1% | ||
| Q2 25 | 14.3% | -11.1% | ||
| Q1 25 | -4.4% | -52.2% | ||
| Q4 24 | -14.9% | -81.2% | ||
| Q3 24 | 8.9% | -89.3% | ||
| Q2 24 | 12.5% | -125.1% | ||
| Q1 24 | -1.9% | -336.5% |
| Q4 25 | -7.0% | — | ||
| Q3 25 | 5.0% | 15.6% | ||
| Q2 25 | 9.3% | -11.1% | ||
| Q1 25 | -5.4% | -50.4% | ||
| Q4 24 | -33.4% | — | ||
| Q3 24 | 3.9% | -87.1% | ||
| Q2 24 | 8.3% | -130.1% | ||
| Q1 24 | -7.1% | -328.9% |
| Q4 25 | $-0.06 | $0.04 | ||
| Q3 25 | $0.07 | $0.28 | ||
| Q2 25 | $0.13 | $-0.14 | ||
| Q1 25 | $-0.05 | $-0.47 | ||
| Q4 24 | $-0.24 | $-0.71 | ||
| Q3 24 | $0.05 | $-0.70 | ||
| Q2 24 | $0.11 | $-0.91 | ||
| Q1 24 | $-0.07 | $-1.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.0M |
| Total DebtLower is stronger | $279.8M | — |
| Stockholders' EquityBook value | $405.9M | $114.8M |
| Total Assets | $823.2M | $605.2M |
| Debt / EquityLower = less leverage | 0.69× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.0M | ||
| Q3 25 | — | $110.9M | ||
| Q2 25 | — | $75.2M | ||
| Q1 25 | — | $61.9M | ||
| Q4 24 | — | $58.5M | ||
| Q3 24 | — | $36.4M | ||
| Q2 24 | — | $32.3M | ||
| Q1 24 | — | $43.3M |
| Q4 25 | $279.8M | — | ||
| Q3 25 | $281.1M | — | ||
| Q2 25 | $281.5M | — | ||
| Q1 25 | $306.9M | — | ||
| Q4 24 | $281.5M | — | ||
| Q3 24 | $282.8M | — | ||
| Q2 24 | $282.4M | — | ||
| Q1 24 | $282.8M | — |
| Q4 25 | $405.9M | $114.8M | ||
| Q3 25 | $408.4M | $73.6M | ||
| Q2 25 | $398.4M | $32.7M | ||
| Q1 25 | $381.1M | $32.8M | ||
| Q4 24 | $387.2M | $59.1M | ||
| Q3 24 | $416.6M | $-30.5M | ||
| Q2 24 | $408.1M | $15.1M | ||
| Q1 24 | $391.8M | $74.1M |
| Q4 25 | $823.2M | $605.2M | ||
| Q3 25 | $844.4M | $538.6M | ||
| Q2 25 | $822.1M | $555.3M | ||
| Q1 25 | $824.6M | $548.8M | ||
| Q4 24 | $794.2M | $594.1M | ||
| Q3 24 | $853.4M | $504.4M | ||
| Q2 24 | $830.0M | $551.1M | ||
| Q1 24 | $808.6M | $663.5M |
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.73× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.69× | — | ||
| Q1 24 | 0.72× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.3M | $60.7M |
| Free Cash FlowOCF − Capex | $14.1M | — |
| FCF MarginFCF / Revenue | 14.1% | — |
| Capex IntensityCapex / Revenue | 9.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $38.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.3M | $60.7M | ||
| Q3 25 | $51.0M | $14.3M | ||
| Q2 25 | $36.0M | $5.0M | ||
| Q1 25 | $-46.9M | $-42.2M | ||
| Q4 24 | $6.2M | $-35.7M | ||
| Q3 24 | $37.2M | $-42.5M | ||
| Q2 24 | $52.4M | $-40.2M | ||
| Q1 24 | $-34.5M | $-119.0M |
| Q4 25 | $14.1M | — | ||
| Q3 25 | $45.2M | $14.2M | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $-50.3M | — | ||
| Q4 24 | $-98.0K | — | ||
| Q3 24 | $33.2M | — | ||
| Q2 24 | $47.9M | $-40.3M | ||
| Q1 24 | $-39.9M | — |
| Q4 25 | 14.1% | — | ||
| Q3 25 | 27.9% | 8.6% | ||
| Q2 25 | 16.8% | — | ||
| Q1 25 | -45.2% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 22.1% | — | ||
| Q2 24 | 29.9% | -74.5% | ||
| Q1 24 | -36.0% | — |
| Q4 25 | 9.2% | — | ||
| Q3 25 | 3.6% | 0.1% | ||
| Q2 25 | 4.0% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 2.7% | 0.0% | ||
| Q2 24 | 2.8% | 0.2% | ||
| Q1 24 | 4.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 6.29× | 0.56× | ||
| Q2 25 | 2.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.32× | — | ||
| Q2 24 | 3.95× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
TVTX
| FILSPARI | $103.3M | 80% |
| Tiopronin Products | $23.3M | 18% |
| License | $3.1M | 2% |
